{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:27:45Z","timestamp":1792517265763,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071057"],"award-info":[{"award-number":["82071057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871473"],"award-info":[{"award-number":["81871473"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.actbio.2025.04.031","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T13:07:42Z","timestamp":1744895262000},"page":"361-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma"],"prefix":"10.1016","volume":"199","author":[{"given":"Wenqing","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyue","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhe","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2986-8968","authenticated-orcid":false,"given":"Songwei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.actbio.2025.04.031_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.actbio.2025.04.031_bib0002","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.actbio.2025.04.031_bib0003","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41568-022-00531-9","article-title":"Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment","volume":"23","author":"Ruffin","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.actbio.2025.04.031_bib0004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumour microenvironments","volume":"21","author":"Certo","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.actbio.2025.04.031_bib0005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"13","key":"10.1016\/j.actbio.2025.04.031_bib0006","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1158\/0008-5472.CAN-18-3726","article-title":"The tumor metabolic microenvironment: lessons from Lactate","volume":"79","author":"Garc\u00eda-Ca\u00f1averas","year":"2019","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.actbio.2025.04.031_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002305","article-title":"Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma","volume":"9","author":"Deng","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.actbio.2025.04.031_bib0008","article-title":"Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy","volume":"19","author":"Huang","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"issue":"8021","key":"10.1016\/j.actbio.2025.04.031_bib0009","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","article-title":"NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance","volume":"631","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2025.04.031_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12964-015-0114-x","article-title":"L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation","volume":"13","author":"Wagner","year":"2015","journal-title":"Cell Commun. Signaling: CCS"},{"issue":"9","key":"10.1016\/j.actbio.2025.04.031_bib0011","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.actbio.2025.04.031_bib0012","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.7150\/ijbs.78248","article-title":"IFN\u03b3 blockade in capillary leak site improves tumour chemotherapy by inhibiting lactate-induced endocytosis of vascular endothelial-cadherins","volume":"19","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"18","key":"10.1016\/j.actbio.2025.04.031_bib0013","doi-asserted-by":"crossref","first-page":"10322","DOI":"10.1021\/jacs.3c02005","article-title":"Nitrogen-centered lactate oxidase nanozyme for tumor lactate modulation and microenvironment remodeling","volume":"145","author":"Zhao","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.actbio.2025.04.031_bib0014","article-title":"Insights into the effect of catalytic intratumoral lactate depletion on metabolic reprogramming and immune activation for antitumoral activity","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"issue":"Pt 3","key":"10.1016\/j.actbio.2025.04.031_bib0015","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.semcancer.2022.10.009","article-title":"Targeting lactate-related cell cycle activities for cancer therapy","volume":"86","author":"Lin","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.actbio.2025.04.031_bib0016","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semcancer.2022.12.001","article-title":"Targeting lactate metabolism for cancer immunotherapy - a matter of precision","volume":"88","author":"Heuser","year":"2023","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.actbio.2025.04.031_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-022-02574-0","article-title":"Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development","volume":"42","author":"Gao","year":"2023","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"6","key":"10.1016\/j.actbio.2025.04.031_bib0018","article-title":"CRISPR\/Cas9 systems: delivery technologies and biomedical applications","volume":"18","author":"Du","year":"2023","journal-title":"Asian J Pharm. Sci."},{"issue":"3","key":"10.1016\/j.actbio.2025.04.031_bib0019","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for Sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6481","key":"10.1016\/j.actbio.2025.04.031_bib0020","article-title":"CRISPR-engineered T cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Sci."},{"issue":"5","key":"10.1016\/j.actbio.2025.04.031_bib0021","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41591-020-0840-5","article-title":"Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer","volume":"26","author":"Lu","year":"2020","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.actbio.2025.04.031_bib0022","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","article-title":"Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update","volume":"86","author":"dos Santos","year":"2012","journal-title":"Arch. Toxicol."},{"issue":"8","key":"10.1016\/j.actbio.2025.04.031_bib0023","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1172\/JCI43656","article-title":"Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice","volume":"121","author":"Lesterhuis","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.actbio.2025.04.031_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.actbio.2025.04.031_bib0025","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.7150\/thno.51797","article-title":"Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.actbio.2025.04.031_bib0026","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41419-023-06195-z","article-title":"Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury","volume":"14","author":"Xie","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.actbio.2025.04.031_bib0027","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12943-024-02193-7","article-title":"Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy","volume":"23","author":"Gan","year":"2024","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.actbio.2025.04.031_bib0028","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.apsb.2019.10.011","article-title":"Platinum complexes of curcumin delivered by dual-responsive polymeric nanoparticles improve chemotherapeutic efficacy based on the enhanced anti-metastasis activity and reduce side effects","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.031_bib0029","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/10611861003733938","article-title":"The involvement of microtubules and actin filaments in the intracellular transport of non-viral gene delivery system","volume":"19","author":"Lam","year":"2011","journal-title":"J. Drug. Target."},{"issue":"5","key":"10.1016\/j.actbio.2025.04.031_bib0030","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1194\/jlr.TR120000658","article-title":"Lipid rafts as a therapeutic target","volume":"61","author":"Sviridov","year":"2020","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.actbio.2025.04.031_bib0031","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/icb.2011.20","article-title":"Macropinocytosis: an endocytic pathway for internalising large gulps","volume":"89","author":"Lim","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.actbio.2025.04.031_bib0032","article-title":"Glutathione hybrid poly (beta-amino ester)-plasmid nanoparticles for enhancing gene delivery and biosafety","author":"Tan","year":"2024","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.actbio.2025.04.031_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16010154","article-title":"Chitosan-functionalized poly(\u03b2-Amino Ester) hybrid system for gene delivery in vaginal mucosal epithelial cells","volume":"16","author":"Gao","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2025.04.031_bib0034","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejpb.2018.05.034","article-title":"The proton sponge hypothesis: fable or fact?","volume":"129","author":"Vermeulen","year":"2018","journal-title":"Eur. J. Pharm. Biopharm.: Official Journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV"},{"key":"10.1016\/j.actbio.2025.04.031_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115323","article-title":"Cisplatin in cancer treatment","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.actbio.2025.04.031_bib0036","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.actbio.2022.08.026","article-title":"Dynamic ginsenoside-sheltered nanocatalysts for safe ferroptosis-apoptosis combined therapy","volume":"151","author":"Zhao","year":"2022","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.actbio.2025.04.031_bib0037","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1039\/D1NA00697E","article-title":"The synthesis of a nanodrug using metal-based nanozymes conjugated with ginsenoside Rg3 for pancreatic cancer therapy","volume":"4","author":"Zhao","year":"2021","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.actbio.2025.04.031_bib0038","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lfs.2019.02.042","article-title":"Renalase attenuates mitochondrial fission in cisplatin-induced acute kidney injury via modulating sirtuin-3","volume":"222","author":"Huang","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.actbio.2025.04.031_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216837","article-title":"The emerging role of lactate in tumor microenvironment and its clinical relevance","volume":"590","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.actbio.2025.04.031_bib0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","article-title":"Navigating metabolic pathways to enhance antitumour immunity and immunotherapy","volume":"16","author":"Li","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.actbio.2025.04.031_bib0041","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","article-title":"Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1","volume":"145","author":"Luo","year":"2011","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.actbio.2025.04.031_bib0042","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1136\/gutjnl-2021-326350","article-title":"PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma","volume":"71","author":"Lu","year":"2022","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.031_bib0043","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","article-title":"Cisplatin nephrotoxicity: new insights and therapeutic implications","volume":"19","author":"Tang","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.actbio.2025.04.031_bib0044","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: cancer's Achilles' heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.actbio.2025.04.031_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176007","article-title":"Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer","volume":"957","author":"Yu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.actbio.2025.04.031_bib0046","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.actbio.2025.04.031_bib0047","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Contr. Release."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125002727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125002727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T07:55:12Z","timestamp":1778313312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125002727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"alternative-id":["S1742706125002727"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.04.031","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}